Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ethical issues in schizophrenia research.

R B Zipursky1

  • 1Centre for Addiction and Mental Health, Clarke Division, Schizophrenia and Continuing Care Program, 250 College Street, 7th Floor, Toronto, ON M5T 1R8, Canada.

Current Psychiatry Reports
|December 21, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A multi-site Canadian perspective: examining the functional outcome from first-episode psychosis.

Acta psychiatrica Scandinavica·2009
Same author

Ethnic diversity and pathways to care for a first episode of psychosis in Ontario.

Schizophrenia bulletin·2008
Same author

Olanzapine and haloperidol in first episode psychosis: two-year data.

Schizophrenia research·2006
Same author

A systematic review of longitudinal outcome studies of first-episode psychosis.

Psychological medicine·2006
Same author

Factorial structure of the Scale of Prodromal Symptoms.

Schizophrenia research·2004
Same author

The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design.

Schizophrenia research·2003

Recent debates highlight ethical concerns in schizophrenia research, focusing on patient consent capacity and researcher conflicts of interest. The ethics of involving individuals with schizophrenia in studies that may worsen symptoms are also under scrutiny.

Area of Science:

  • Bioethics
  • Psychiatric Research
  • Schizophrenia Studies

Background:

  • Intense debate surrounds ethical issues in schizophrenia research, amplified by a recent National Bioethics Advisory Commission (NBAC) report and media coverage.
  • Key ethical questions involve the capacity of individuals with mental illness to provide informed consent for research participation.
  • Conflicts of interest experienced by psychiatric researchers are also a significant area of ethical concern.

Purpose of the Study:

  • To examine the ethical considerations surrounding research with individuals diagnosed with schizophrenia.
  • To address the debate on informed consent capacity in mentally ill populations.
  • To explore the ethical implications of research designs that may exacerbate psychotic symptoms.

Main Methods:

Related Experiment Videos

  • Analysis of the National Bioethics Advisory Commission (NBAC) final report.
  • Review of recent media reports and public discourse on schizophrenia research ethics.
  • Examination of ethical principles related to research participation and informed consent in vulnerable populations.

Main Results:

  • Significant ethical questions have been raised regarding the capacity of individuals with mental illness to consent to research.
  • Concerns exist about potential conflicts of interest among psychiatric researchers.
  • The ethical permissibility of research that might increase psychotic symptoms in schizophrenia patients is under intense scrutiny.

Conclusions:

  • The ethical landscape of schizophrenia research requires careful consideration of participant vulnerability and researcher integrity.
  • Further dialogue and ethical guidelines are necessary to ensure responsible research practices.
  • Addressing consent capacity and potential symptom exacerbation is crucial for ethical schizophrenia research.